Merck & Co - Pharmaceutical Company Impresses with Strong Pipeline!
Reading Time: 1 minute
Business Drivers: Merck & Co (MRK) is particularly strong in the oncology segment, primarily thanks to Keytruda, and also has numerous blockbuster drugs in other segments such as vaccines, diabetes medications, and inflammatory diseases. With the approval of WINREVAIR (Pulmonary Hypertension) and the pneumococcal vaccine Capvaxive developed specifically for adults aged 18 and older, Merck & Co has good opportunities in its core business. The recent acquisition of Verona Pharma has secured the rights to the COPD drug Ohtuvayre, which has...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
